adalimumab-ryvk
Generic: adalimumab-ryvk
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
adalimumab-ryvk
Generic Name
adalimumab-ryvk
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
KIT
Manufacturer
Identifiers & Regulatory
Product NDC
51759-360
Product ID
51759-360_ed0b2de6-71a4-439f-a464-f7383cf5dd4e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761299
Listing Expiration
2026-12-31
Marketing Start
2025-07-01
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51759360
Hyphenated Format
51759-360
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adalimumab-ryvk (source: ndc)
Generic Name
adalimumab-ryvk (source: ndc)
Application Number
BLA761299 (source: ndc)
Resolved Composition
Strengths
- 80 mg/0.8 ml
- 40 mg/0.4 ml
- 20 mg/0.2 ml
- 1 ml
Packaging
- 2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-368-21) * .4 mL in 1 POUCH (65517-0002-1)
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "ed0b2de6-71a4-439f-a464-f7383cf5dd4e", "openfda": {"rxcui": ["797544", "2677780", "2706644"], "spl_set_id": ["2d19a877-1f5a-4731-800a-dddadc424080"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 KIT in 1 CARTON (51759-360-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-368-21) * .4 mL in 1 POUCH (65517-0002-1)", "package_ndc": "51759-360-02", "marketing_start_date": "20250701"}], "brand_name": "Adalimumab-ryvk", "product_id": "51759-360_ed0b2de6-71a4-439f-a464-f7383cf5dd4e", "dosage_form": "KIT", "product_ndc": "51759-360", "generic_name": "adalimumab-ryvk", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adalimumab-ryvk", "application_number": "BLA761299", "marketing_category": "BLA", "marketing_start_date": "20250701", "listing_expiration_date": "20261231"}